The Journal of Organic Chemistry
Page 6 of 8
(ESI-TOF) m/z: [M + Na]+ calcd for C11H12ClNNaO2: 248.0449,
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C11H14NS2: 224.0562,
found: 224.0557. MP: 63.3-66.9 oC.
found: 248.0447. MP: 59.0-66.4 oC.
1
2
3
4
5
6
7
8
9
5-(4-bromophenyl)-3-ethyloxazolidin-2-one (6g).15 White solid.
Yield: 73%, 392.7 mg; 1H NMR (400 MHz, DMSO-d6): δ 7.63 (d,
J = 8.4 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 5.62–5.48 (m, 1H), 3.96
(s, 1H), 3.41–3.37 (m, 1H), 3.29–3.17 (m, 2H), 1.08 (t, J = 7.2 Hz,
3H)ppm. 13C NMR (100 MHz, DMSO-d6): δ 161.9, 143.9, 136.88,
133.4, 126.9, 78.2, 55.6, 43.5, 17.5 ppm. HRMS (ESI-TOF) m/z:
[M + Na]+ calcd for C11H12BrNNaO2: 291.9944, found: 291.9938.
MP: 57.8-65.5 oC.
5-phenyl-3-propylthiazolidine-2-thione (10b). Yellow solid. Yield:
97%, 229.9 mg; H NMR (400 MHz, CDCl3): δ 7.47 –7.30 (m,
1
5H), 4.91–4.77 (m, 1H), 4.40 (dd, J = 11.6, 8.4 Hz, 1H), 4.08 (dd,
J = 11.6, 6.9 Hz, 1H), 3.89–3.67 (m, 2H), 1.82–1.62 (m, 2H), 0.97
(q, J = 7.1 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 195.3,
138.2, 128.7, 128.1, 126.8, 63.7, 50.3, 46.6, 19.7, 10.8 ppm.
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C12H16NS2: 238.0719,
found: 238.0705. MP: 53.2-54.7 oC.
3-ethyl-5-(p-tolyl)oxazolidin-2-one (6h).5i White solid. Yield:
87%, 356.9 mg; 1H NMR (400 MHz, CDCl3): δ 7.21 (dd, J = 19.7,
8.1 Hz, 4H), 5.43 (t, J = 8.1 Hz, 1H), 3.89 (t, J = 8.7 Hz, 1H),
3.44–3.27 (m, 3H), 2.35 (s, 3H), 1.17 (td, J = 7.2, 0.5 Hz, 3H)
ppm. 13C NMR (100 MHz, CDCl3): δ 157.7, 138.6, 135.8, 129.5,
125.6, 74.4, 51.6, 38.9, 21.2, 12.6 ppm. HRMS (ESI-TOF) m/z:
[M + Na]+ calcd for C12H15NNaO2: 228.0995, found: 228.0998.
MP: 53.6-55.9 oC.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3-butyl-5-phenylthiazolidine-2-thione (10c). Yellow solid. Yield:
87%, 218.4 mg; H NMR (400 MHz, CDCl3):δ 7.41– 7.29 (m,
1
5H), 4.84 (dd, J = 8.2, 7.0 Hz, 1H), 4.38 (dd, J = 11.6, 8.3 Hz,
1H), 4.05 (dt, J = 12.9, 6.4 Hz, 1H), 3.85 – 3.71 (m, 2H), 1.71–
1.58 (m, 2H), 1.43–1.31 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H) ppm.
13C NMR (100 MHz, CDCl3): δ 195.5, 138.7, 129.1, 128.5, 127.3,
64.1, 49.1, 47.1, 28.8, 20.1, 13.8 ppm. HRMS (ESI-TOF) m/z: [M
+ H]+ calcd for C13H18NS2: 252.0875, found: 252.0866. MP: 53.4-
55.1 oC.
5-(4-(tert-butyl)phenyl)-3-ethyloxazolidin-2-one (6i). White liquid.
1
Yield: 82%, 405.3 mg; H NMR (400 MHz, CDCl3): δ 7.42 (d, J
3-isobutyl-5-phenylthiazolidine-2-thione (10d). Yellow solid.
Yield: 83%, 208.4 mg; 1H NMR (400 MHz, CDCl3): δ 7.38 –7.22
(m, 5H), 4.83–4.73 (m, 1H), 4.29 (dd, J = 11.6, 8.3 Hz, 1H), 3.98
(dd, J = 11.6, 7.1 Hz, 1H), 3.56 (qd, J = 13.4, 7.6 Hz, 2H), 2.04
(dp, J = 13.7, 6.9 Hz, 1H), 0.93–0.83 (m, 6H) ppm. 13C NMR
(100 MHz, CDCl3): δ 195.9, 138.0, 128.6, 128.1, 126.9, 64.3, 55.9,
46.8, 26.9, 19.7 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C13H18NS2: 252.0875, found: 252.0865. MP: 54.7-55.3 oC.
= 8.4 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.46 (t, J = 8.1 Hz, 1H),
3.91 (t, J = 8.7 Hz, 1H), 3.49–3.28 (m, 3H), 1.33 (s, 9H), 1.19 (t, J
= 7.2 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ 157.3, 151.3,
135.3, 125.3, 124.9, 73.8, 51.0, 38.4, 30.8, 12.1 ppm. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd for C15H21NNaO2: 270.1465,
found: 270.1464.
3-ethyl-5-(4-methoxyphenyl)oxazolidin-2-one (6j). White solid.
1
3-benzyl-5-phenylthiazolidine-2-thione (10e).10b Yellow solid.
Yield: 71%, 202.4 mg; 1H NMR (400 MHz, CDCl3): δ 7.40 –7.24
(m, 10H), 5.02 (dd, J = 33.4, 14.6 Hz, 2H), 4.86–4.74 (m, 1H),
4.23 (dd, J = 11.6, 8.4 Hz, 1H), 3.93 (dd, J = 11.7, 7.2 Hz, 1H)
ppm. 13C NMR (100 MHz, CDCl3): δ 196.5, 138.4, 134.9, 129.1,
129.0, 128.5, 128.4, 128.4, 127.3, 63.2, 52.7, 46.9 ppm. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd for C16H15NNaS2: 308.0538,
found: 308.0544. MP: 115.2-118.7 oC.
Yield: 43%, 190.1 mg; H NMR (400 MHz, CDCl3): δ 7.30 (d, J
= 8.3 Hz, 2H), 6.93 (d, J = 8.2 Hz, 2H), 5.43 (t, J = 8.0 Hz, 1H),
3.89 (t, J = 8.6 Hz, 1H), 3.82 (s, 3H), 3.40 (ddd, J = 20.4, 14.9,
7.5 Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H) ppm. 13C NMR (100 MHz,
CDCl3): δ 160.0, 157.7, 130.7, 127.2, 114.2, 74.3, 55.4, 51.6, 38.9,
12.6 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for
C12H15NNaO3: 244.0944, found: 244.0940. MP: 68.3-72.1 oC.
5-phenyloxazolidin-2-one (6k).5h Colorless liquid. Yield: 54%,
176.1 mg; 1H NMR (400 MHz, CDCl3): δ 7.47–7.31 (m, 5H),
5.75 (s, 1H), 5.63 (t, J = 8.2 Hz, 1H), 3.99 (t, J = 8.7 Hz, 1H),
3.60–3.50 (m, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ 160.41,
138.5, 128.9, 127.4, 125.8, 78.0, 48.4 ppm. HRMS (ESI-TOF)
m/z: [M + Na]+ calcd for C9H9NNaO2: 186.0525, found: 186.0523.
5-(4-chlorophenyl)-3-ethylthiazolidine-2-thione (10f). Yellow
solid. Yield: 89%, 228.7 mg; 1H NMR (400 MHz, CDCl3): δ
7.30–7.21 (m, 4H), 4.73 (dd, J = 8.2, 6.5 Hz, 1H), 4.32 (dd, J =
11.6, 8.3 Hz, 1H), 3.94 (dd, J = 11.6, 6.5 Hz, 1H), 3.79 (ddt, J =
20.8, 13.6, 6.9 Hz, 2H), 1.19 (t, J = 7.2 Hz, 3H) ppm. 13C NMR
(100 MHz, CDCl3): δ 194.5, 137.0, 133.9, 128.8, 128.2, 62.9, 45.7,
43.7, 11.1 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C11H13ClNS2: 258.0172, found: 258.0163. MP: 91.4-92.9 oC.
General procedure for the catalytic ring-opening reaction of
aziridines with CS2. All manipulations and reactions were con-
ducted under a purified argon atmosphere by using standard
Schlenk techniques. A 5 mL Schlenk tube under dried argon was
charged with complex 1 (0.01 mmol), aziridine (1 mmol) and a
stirring bar. After the catalyst was dissolved, CS2 (5 mmol) was
added into the tube. The reaction mixture was stirred at oil bath of
5-(4-bromophenyl)-3-ethylthiazolidine-2-thione (10g). Yellow
solid. Yield: 85%, 255.8 mg; 1H NMR (400 MHz, CDCl3): δ 7.42
(d, J = 8.5 Hz, 2H), 7.22–7.16 (m, 2H), 4.77–4.63 (m, 1H), 4.32
(dd, J = 11.6, 8.3 Hz, 1H), 3.94 (dd, J = 11.6, 6.5 Hz, 1H), 3.87–
3.66 (m, 2H), 1.18 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (100 MHz,
CDCl3): δ 194.4, 137.5, 131.8, 128.5, 122.0, 62.9, 45.8, 43.7, 11.2
o
45 C for 24 h, then cooled down to room temperature, quenched
with ethyl acetate, then biphenyl (0.5 mmol) was added as an
internal standard for the analysis of product by GC. The crude
mixture was purified by column chromatography on silica gel
(200−300 mesh, eluting with 20:1 petroleum ether/ethyl acetate to
give desired products).
ppm. HRMS
(ESI-TOF) m/z: [M +
Na]+ calcd for
C11H12BrNNaS2: 323.9487, found: 323.9474. MP: 103.6-105.1 oC.
3-ethyl-5-(p-tolyl)thiazolidine-2-thione (10h). Yellow solid. Yield:
1
85%, 201.5 mg; H NMR (400 MHz, CDCl3): δ 7.22 –7.17 (m,
2H), 7.09 (d, J = 8.0 Hz, 2H), 4.79–4.71 (m, 1H), 4.28 (dd, J =
11.5, 8.3 Hz, 1H), 3.97 (dd, J = 11.6, 7.1 Hz, 1H), 3.87–3.70 (m,
2H), 2.27 (s, 3H), 1.18 (d, J = 7.2 Hz, 3H) ppm. 13C NMR (100
MHz, CDCl3): δ 195.4, 138.5, 135.6, 129.8, 127.2, 63.6, 46.8,
44.2, 21.1, 11.7 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C12H16NS2: 238.0719, found: 238.0711. MP: 63.5-64.9 oC.
Characterization data of thiazolidine-2-thiones. 3-ethyl-5-
phenylthiazolidine-2-thione (10a).5g Yellow solid. Yield: 95%,
1
211.9 mg; H NMR (400 MHz, CDCl3): δ 7.46– 7.29 (m, 5H),
4.84 (dd, J = 8.2, 7.1 Hz, 1H), 4.38 (dd, J = 11.5, 8.4 Hz, 1H),
4.07 (dd, J = 11.6, 7.0 Hz, 1H), 3.87 (ddd, J = 14.2, 9.1, 6.9 Hz,
2H), 1.26 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (100 MHz, CDCl3):
δ 194.7, 138.3, 128.7, 128.1, 126.8, 63.0, 46.5, 43.7, 11.2 ppm.
5-(4-(tert-butyl)phenyl)-3-ethylthiazolidine-2-thione (10i). Yellow
solid. Yield: 70%, 195.4 mg; 1H NMR (400 MHz, CDCl3): δ 7.34
ACS Paragon Plus Environment